Activation of nuclear receptors by prostaglandins
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 110 (5-6) , 311-315
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- 15 R-Methyl-Prostaglandin D2 Is a Potent and Selective CRTH2/DP2 Receptor Agonist in Human EosinophilsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Genetic and pharmacological analysis of prostanoid receptor functionJournal of Clinical Investigation, 2001
- Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2Journal of Experimental Medicine, 2001
- Identification of the platelet ADP receptor targeted by antithrombotic drugsNature, 2001
- Prostaglandin D 2 as a Mediator of Allergic AsthmaScience, 2000
- Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human PlateletsJournal of Biological Chemistry, 1999
- Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3Nature, 1998
- Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonistsThe American Journal of Cardiology, 1991
- Regulatory role of cyclic adenosine 3′,5′-monophosphate on the plattelet cyclooxygenase and platelet functionBiochimica et Biophysica Acta (BBA) - General Subjects, 1979